Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT04701372 · ClinicalTrials.gov registry record

Clinical Outcomes From NOCD Treatment of Obsessive-Compulsive Disorder Using Exposure and Response Prevention

A clinical trial of Obsessive - Compulsive Disorder, sponsored by NOCD.

Completed
Registry status
2,069
Enrollment target
1
Study location

NCT04701372 is a study of Obsessive - Compulsive Disorder that has completed, run by NOCD. The registered enrollment target is 2,069 participants, roughly in line with the 2,040-participant average among 84 other Obsessive - Compulsive Disorder trials with a reported enrollment target. The trial reports 1 study location across 1 state.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT04701372, a study of Obsessive - Compulsive Disorder, has completed, sponsored by NOCD.

COMPLETED
Registry status
2,069 participants
Enrollment target
1
Study location

Study Summary

This is a naturalistic, observational study of individuals with obsessive-compulsive disorder who were treated with exposure and response prevention via video teletherapy, augmented with between-session support with text messaging and an online community forum.

Interventions

  • BEHAVIORAL Exposure and response prevention therapy

Study Locations (1)

Illinois

  • Nocd, Llc - Chicago

Trial Details

FieldValue
Enrollment Target 2,069 participants
Start Date 2020-01-01
Est. Completion 2020-11-08

Sponsor

NOCD

2 total trials

What the Registry Record Tells You About NCT04701372

The ClinicalTrials.gov registry entry for NCT04701372 describes a study currently listed as completed, categorized as an unspecified phase. The registered enrollment target is 2,069 participants, a figure that helps gauge the scale of data the investigators plan to collect, roughly in line with the 2,040-participant average among 84 other Obsessive - Compulsive Disorder trials with a reported enrollment target. The listed sponsor is NOCD, which has 2 total studies on file at ClinicalTrials.gov.

The record links to 1 condition, with Obsessive - Compulsive Disorder appearing as the primary indexed condition, and to 1 intervention - of which Exposure and response prevention therapy is the first listed.

NCT04701372 reports 1 study location spanning 1 distinct geographic area - top geographies include Illinois.

Frequently Asked Questions

What is clinical trial NCT04701372 about?

NCT04701372 is a clinical study titled "Clinical Outcomes From NOCD Treatment of Obsessive-Compulsive Disorder Using Exposure and Response Prevention". This is a naturalistic, observational study of individuals with obsessive-compulsive disorder who were treated with exposure and response prevention via video teletherapy, augmented with between-session support with text messaging and an online community forum.

What is the current status of trial NCT04701372?

This trial is currently completed. The enrollment target is 2,069 participants. The study started on 2020-01-01. Estimated completion is 2020-11-08.

What conditions does trial NCT04701372 study?

This clinical trial studies the following conditions: Obsessive - Compulsive Disorder.

What interventions are being tested in trial NCT04701372?

The interventions under investigation include: Exposure and response prevention therapy (BEHAVIORAL).

Who is sponsoring clinical trial NCT04701372?

This trial is sponsored by NOCD, which has 2 total clinical trials registered on ClinicalTrials.gov.

Where is trial NCT04701372 being conducted?

This trial has 1 study location across Illinois. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.

Similar trials for Obsessive - Compulsive Disorder

Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.

Data sourced from official public datasets. See our methodology for details. Retrieved and formatted by PlainTrial Editorial

Every figure on PlainTrial is rendered directly from the ClinicalTrials.gov registry, no number is typed in by an editor. This page mirrors this trial's own ClinicalTrials.gov registry record, live from the dataset. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error.